CogState Ltd
ASX:CGS
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
CogState Ltd
Free Cash Flow
CogState Ltd
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CogState Ltd
ASX:CGS
|
Free Cash Flow
-$1.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
10%
|
|
Mach7 Technologies Ltd
ASX:M7T
|
Free Cash Flow
AU$5.1m
|
CAGR 3-Years
191%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
4DMedical Ltd
ASX:4DX
|
Free Cash Flow
-AU$28.8m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
Pro Medicus Ltd
ASX:PME
|
Free Cash Flow
AU$64.9m
|
CAGR 3-Years
40%
|
CAGR 5-Years
56%
|
CAGR 10-Years
48%
|
|
Medibio Ltd
ASX:MEB
|
Free Cash Flow
-AU$3.2m
|
CAGR 3-Years
15%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Medadvisor Ltd
ASX:MDR
|
Free Cash Flow
-AU$5.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-2%
|
See Also
What is CogState Ltd's Free Cash Flow?
Free Cash Flow
-1.2m
USD
Based on the financial report for Dec 31, 2023, CogState Ltd's Free Cash Flow amounts to -1.2m USD.
What is CogState Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
10%